Bajaj Finserv Healthcare Fund Regular Growth NAV today
AMFI: 153155ISIN: INF0QA701987MUTF_IN: BAJA_HEAL_REG_MHZJ31Bajaj Finserv Mutual FundSectoral / Thematic funds
NAV ₹10.7330down ₹0.11 (0.98%)
NAV for 23 Oct 2026, against 22 Oct 2026. Declared once a day.
- Fund sizeAssets under management. The money the fund manages for all its investors, across every plan, at the end of the month.
- ₹405 CrSep 2026
- Expense ratioTotal expense ratio. What the fund charges each year as a share of the money invested, taken out of the NAV every day, so the returns shown are already after it.
- 2.59%16 Oct 2026
- P/EP/E. What the fund pays for each rupee of yearly profit its companies earn: the total value of its shares divided by those companies' last four quarters of profit, each in proportion to what the fund holds. The profit leaves out one-off items (exceptional items and businesses sold or demerged), so one company's one-off gain cannot make the fund look cheap. A loss-making company lowers the profit. Shown when at least 80% of the fund's shares are counted.
- 49.230 Sep 2026
- Risk levelRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month.
- Very HighAug 2026
- HoldingsHoldings. The number of different securities in the fund's latest monthly portfolio: shares, bonds, money market paper and units of other funds, not cash, overnight lending or futures.
- 3430 Sep 2026
- LaunchedLaunch date. The day the fund first allotted units to investors, at the close of its new fund offer.
- 27 Dec 2024
Bajaj Finserv Healthcare Fund returns
Regular Growth plan
Over each window to 23 Oct 2026
| Over | ReturnTrailing return. The change in NAV from the start date to the latest NAV; over a year and longer, the yearly rate that would compound to the same change (CAGR). | BenchmarkBenchmark. The index the fund house chose to measure the fund against, in its total return form, with dividends added back. | Rank in categoryRank in category. The fund's place among the funds of its category with a return over the same window, highest return first. | Category medianCategory median. The middle return of the funds in the category over the same window: half returned more, half less. | Middle halfMiddle half of the category. The returns of the fund a quarter of the way down the category and the fund a quarter of the way up, over the same window: half the category's funds returned between the two. |
|---|---|---|---|---|---|
| 1 week | −2.85% | – | – | – | – |
| 1 month | −10.31% | – | 219 of 254 | −8.33% | −9.6% to −6.7% |
| 3 months | −3.38% | – | 43 of 249 | −6.53% | −8.0% to −4.6% |
| 6 months | +10.29% | – | 11 of 249 | −4.08% | −6.9% to +1.7% |
| 1 year | +8.26% | +16.77%to 30 Sep 2026 | 17 of 228 | −6.21% | −10.1% to −0.6% |
| 3 years | Needs 3 years | – | – | +10.84% | +7.2% to +15.3% |
| 5 years | Needs 5 years | – | – | +9.47% | +6.9% to +13.1% |
| 10 years | Needs 10 years | – | – | +12.66% | +10.6% to +14.0% |
₹10,000 put in on 30 Dec 2024 is ₹10,649 at the NAV of 23 Oct 2026Growth of ₹10,000. What ₹10,000 put in at the NAV of the first day would be worth at the latest NAV, after the fund's expenses and before tax and any exit load.Over a year and longer, a return is the yearly rate. Benchmark: BSE Healthcare TRI, over the same days as the fund, or to the month end its cell names. Rank, median and middle half among the Regular plans of Sectoral / Thematic funds, each fund's return to its latest NAV on or before 25 Oct 2026.
At the month end, 30 Sep 2026
| Over | FundTrailing return. The change in NAV from the start date to the latest NAV; over a year and longer, the yearly rate that would compound to the same change (CAGR). | BenchmarkBenchmark return. The change in the benchmark index's total return level over the same dates as the fund's return, as a yearly rate over a year and longer. |
|---|---|---|
| 1 year | +21.11% | +16.77% |
| Since launch | +8.01% | +7.34% |
Benchmark: BSE Healthcare TRI. Both as the fund house states them for the month.
Return in each calendar year
- Fund, Regular GrowthCalendar year return. The change in NAV from the last NAV of one year to the last NAV of the next.
- Loss
Bajaj Finserv Healthcare Fund SIP returns
₹10,000 on the 1st of every month, valued at the NAV of 23 Oct 2026
| Period | InvestedAmount invested. ₹10,000 on the 1st of every month, or the next day the fund priced, added up over the period. | Value todayValue today. What the units bought by every instalment are worth at the latest NAV. | Invested against value today | SIP returnSIP return (XIRR). The yearly rate that, applied to each monthly instalment from the day it was invested, gives the value of all the units today. | After stamp dutySIP return after stamp duty. The same SIP return with stamp duty of 0.005% taken from every instalment since 1 Jul 2020, so ₹10,000 buys ₹9,999.50 of units. | Stamp dutyStamp duty paid. The stamp duty on all the instalments, in rupees: 0.005% of each purchase made since 1 Jul 2020. |
|---|---|---|---|---|---|---|
| 1 year12 instalments | ₹1,20,000 | ₹1,26,661₹1,26,654 after stamp duty | +10.93% | +10.92% | ₹6 | |
| Since Dec 202422 instalments | ₹2,20,000 | ₹2,40,768₹2,40,756 after stamp duty | +9.99% | +9.99% | ₹11 |
3 years: Launched 27 Dec 2024, needs 3 years of history.
Bajaj Finserv Healthcare Fund expense ratio and exit load
Per cent of the money invested, a year. Each month shows its last day filed; the parts were redefined from Apr 2026.
- Regular over directDirect and regular plan cost gap. The regular plan's expense ratio less the direct plan's: what buying through a distributor costs each year, since both plans own the same portfolio.
- 1.69 ptsA year, on 16 Oct 2026
- Direct, 30-day averageExpense ratio, 30-day average. The total expense ratio averaged over the last 30 days the fund filed it, which evens out the day-to-day moves in brokerage and levies.
- 0.90%Over the last 30 days filed
- Regular, 30-day averageExpense ratio, 30-day average. The total expense ratio averaged over the last 30 days the fund filed it, which evens out the day-to-day moves in brokerage and levies.
- 2.59%Over the last 30 days filed
Total expense ratio, month by month
- Regular plan
- Direct plan
Direct plan highest 0.92%, Jun 2026.Direct plan lowest 0.61%, Mar 2025.
What the expense ratio is made of
| Part | Direct | Regular |
|---|---|---|
| Base expense ratioBase expense ratio. The part of the expense ratio that pays the fund house and the distributor, before brokerage, transaction costs, levies and GST. | 0.66% | 2.09% |
| Brokerage | 0.04% | 0.04% |
| Transaction costs | None | None |
| Statutory levies | 0.20% | 0.46% |
Per cent of assets a year, filed for 16 Oct 2026. The parts add up to that day's total.
Exit load, in the fund house's words
Entry load – Nil Exit load – For each purchase of units through Lumpsum / switch-in / Systematic Investment Plan (SIP) and Systematic Transfer Plan (STP), exit load will be as follows: • if units are redeemed / switched out within 3 months from the date of allotment: 1% of applicable NAV. • if units are redeemed/switched out after 3 months from the date of allotment, no exit load is payable. The Scheme will not levy exit load in case the timelines for rebalancing portfolio as stated in SEBI Master Circular for Mutual Funds dated June 27, 2024, is not complied with. The Trustee / AMC reserves the right to change the load structure any time in the future if they so deem fit on a prospective basis. The investor is requested to check the prevailing load structure of the scheme before investing.MoreLess
Buying and selling
- Lump-sum purchases
- Accepted
- Minimum investmentMinimum investment. The smallest amount the plan accepts for a first purchase.
- ₹500
- Minimum top-up
- ₹100
- Minimum redemption
- ₹500
- SIP
- Accepted
- SIP minimum
- ₹500
- SIP instalments, at least
- 6
- STP, transfers to another fund
- Not accepted
- SWP, regular withdrawals
- Accepted
- Switches
- Accepted
- Lock-inLock-in. The time after each purchase during which those units cannot be sold.
- None
- SIP dates
- Daily, Weekly - Tuesday will be the default day, Fortnightly - 1st & 16th day of each month
As listed for this plan on 24 Oct 2026.
Bajaj Finserv Healthcare Fund AUM
₹ crore, every plan of the fund together.
- Average assetsAverage assets under management. The money the fund managed, averaged over every day of the quarter, added up across its plans.
- ₹389 CrQuarter to Sep 2026
- In the direct plansShare of assets in the direct plans. The direct plans' average assets for the quarter as a percentage of the fund's total; the rest is in the regular plans, bought through distributors.
- 13.0%Of the quarter's average
Average assets by quarter, by plan
- Regular plans
- Direct plans
The latest quarter is the largest since the quarter to Dec 2024.
Assets at each month end
Highest ₹406 Cr, Aug 2026.Lowest ₹300 Cr, Mar 2026.
Bajaj Finserv Healthcare Fund portfolio
Portfolio disclosed for 30 Sep 2026.
Holdings on 30 Sep 2026
| Large, mid and small cap. Companies ranked by average market value over six months: the first 100 are large cap, the next 150 mid cap, the rest small cap, by the list in force for the portfolio's month. | Weight in the fund. The holding's market value on the portfolio date as a share of the fund's net assets. | Held since. The first month end of the fund's current run of holding this position; marked "or earlier" where that month is the fund's first portfolio on record or the first after a gap in its portfolios. | ||||
|---|---|---|---|---|---|---|
| Divi's LaboratoriesPharmaceuticals & Biotechnology | Shares | Large cap50th | 9.75% | 39.52 | 42,533 | Dec 2024or earlier |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | Shares | Large cap13th | 8.96% | 36.30 | 1,99,824 | Dec 2024or earlier |
| Piramal PharmaPharmaceuticals & Biotechnology | Shares | Small cap331st | 6.36% | 25.75 | 12,46,805 | Dec 2024or earlier |
| Rubicon ResearchPharmaceuticals & Biotechnology | Shares | Small cap429th | 6.08% | 24.61 | 1,51,995 | Oct 2025 |
| Aurobindo PharmaPharmaceuticals & Biotechnology | Shares | Mid cap138th | 6.03% | 24.43 | 1,46,132 | Apr 2025 |
| Apollo Hospitals EnterpriseHealthcare Services | Shares | Large cap97th | 5.51% | 22.34 | 27,355 | Dec 2024or earlier |
| Torrent PharmaceuticalsPharmaceuticals & Biotechnology | Shares | Large cap61st | 4.78% | 19.36 | 40,333 | Jan 2025 |
| Emcure PharmaceuticalsPharmaceuticals & Biotechnology | Shares | Small cap266th | 4.03% | 16.33 | 84,054 | Dec 2024or earlier |
| Laurus LabsPharmaceuticals & Biotechnology | Shares | Mid cap171st | 3.91% | 15.84 | 80,000 | Mar 2026 |
| Neuland LaboratoriesPharmaceuticals & Biotechnology | Shares | Small cap356th | 3.82% | 15.46 | 7,242 | Dec 2024or earlier |
| Max Healthcare InstituteHealthcare Services | Shares | Mid cap111th | 2.99% | 12.12 | 1,30,366 | May 2025 |
| Alkem LaboratoriesPharmaceuticals & Biotechnology | Shares | Mid cap164th | 2.96% | 12.00 | 23,236 | Sep 2026 |
| Zydus LifesciencesPharmaceuticals & Biotechnology | Shares | Mid cap114th | 2.57% | 10.41 | 89,621 | May 2026 |
| IPCA LaboratoriesPharmaceuticals & Biotechnology | Shares | Mid cap229th | 2.40% | 9.73 | 50,483 | Dec 2024or earlier |
| Fortis HealthcareHealthcare Services | Shares | Mid cap156th | 2.28% | 9.25 | 1,20,183 | May 2025 |
Weight is per cent of the fund's net assets; value in ₹ crore.
Cash and receivables on 30 Sep 2026
| Weight in the fund. The holding's market value on the portfolio date as a share of the fund's net assets. | ||
|---|---|---|
| Clearing Corporation of India Ltd | 2.32% | 9.39 |
| Net Receivables / (Payables) | 0.81% | 3.32 |
Weight is per cent of the fund's net assets; value in ₹ crore.
- Largest holdingLargest holding. The share of the fund in its single largest position, cash and futures not counted as positions.
- 9.75%Divi's Laboratories
- Top 5 holdingsTop 5 holdings. The share of the fund held in its five largest positions.
- 37.18%
- Top 10 holdingsTop 10 holdings. The share of the fund held in its ten largest positions.
- 59.23%
- Effective holdingsEffective number of holdings. The number of equal-sized positions that would be as concentrated as the fund's actual weights.
- 20.3Taken over 96.87% of the fund
Asset allocation
Asset allocation. What the fund owns, by kind of asset, each as a share of its net assets; futures and options are shown beside it, not in it, since they are contracts rather than assets bought.- Indian shares95.56%
- Units of other funds1.31%
- Cash and receivables3.13%
Per cent of the fund's net assets.
Large, mid and small cap
Large, mid and small cap. Companies ranked by average market value over six months: the first 100 are large cap, the next 150 mid cap, the rest small cap, by the list in force for the portfolio's month.- Large cap31.74%Category 49.50%
- Mid cap30.13%Category 21.62%
- Small cap38.13%Category 26.68%
Per cent of the fund's Indian shares. By the list for the six months to Jun 2026. Category is the average of 249 Sectoral / Thematic funds.
Sector allocation
Sector weight. The fund's shares grouped by the business each company is in, less the futures sold on them, each group as a share of the fund's net assets.5sectors
- Healthcare89.35%Category 12.70%
- Fast Moving Consumer Goods2.20%Category 4.73%
- Consumer Durables1.88%Category 3.48%
- Chemicals1.38%Category 1.97%
- Financial Services0.75%Category 21.68%
Per cent of the fund's net assets, less the futures sold on its shares, Sep 2026. Category is the average of 254 Sectoral / Thematic funds. Category average. The sector's weight, less the futures sold on it, averaged over the 254 Sectoral / Thematic funds that disclosed a portfolio for Sep 2026. A fund holding none of the sector counts as 0.
Sector allocation month by month
| 13 months | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare27 companies | 89.35% | 88.25% | 87.60% | 85.59% | 84.77% | 84.93% | 83.60% | 84.28% | 79.48% | 83.39% | 82.61% | 84.51% | |
| Fast Moving Consumer Goods1 company | 2.20% | 2.27% | 2.66% | 2.82% | 2.65% | 5.27% | 4.95% | 7.14% | 7.40% | 7.78% | 7.31% | 6.33% | |
| Consumer Durables1 company | 1.88% | 2.00% | 2.02% | 2.03% | 2.23% | 1.94% | 1.72% | 1.54% | 1.54% | 1.72% | 1.91% | 1.68% | |
| Chemicals3 companies | 1.38% | 1.45% | 2.28% | 2.17% | 2.14% | 2.11% | 2.05% | 1.99% | 0.00% | 0.00% | 0.00% | 0.41% | |
| Financial Services1 company | 0.75% | 1.74% | 1.79% | 2.04% | 2.03% | 1.07% | 0.99% | 1.18% | 1.31% | 1.41% | 1.41% | 1.71% | |
| Capital Goods | 0.00% | 0.26% | 0.23% | 0.32% | 0.59% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Automobile And Auto Components | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Consumer Services | 0.00% | 0.00% | 0.00% | 1.18% | 1.39% | 1.39% | 1.44% | 1.39% | 5.38% | 3.27% | 2.01% | 1.17% | |
| Information Technology | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Oil Gas & Consumable Fuels | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Telecommunication | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Power | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Per cent of the fund's net assets, less the futures sold on its shares, at each month end, Oct 2025 to Sep 2026; the line runs from Sep 2025.
Bought and sold
Sep 2026 against Aug 2026, position by position.
Positions changed, month by month
- New
- Added
- Trimmed
- Sold out
- New positionsNew positions. Holdings in this month's portfolio that were not in the month before.
- 12.96% of the fund
- Sold outSold out. Holdings in last month's portfolio that are gone from this one, other than a bond or deposit repaid on its due date.
- 21.18% of the fund before
- Added toAdded to. Holdings with more units than the month before. Where the fund states no units, a weight that rose by more than a tenth.
- 2
- TrimmedTrimmed. Holdings with fewer units than the month before. Where the fund states no units, a weight that fell by more than a tenth.
- 2
- UnchangedUnchanged. Holdings with the same number of units as the month before. Their weight can still move with the price.
- 29
- Traded at leastTraded at least. The smaller of the weight bought in new positions and the weight sold out of old ones, cash left out: the least the fund must have bought and sold in the month.
- 1.18%
- Weight that movedWeight that moved. Half the sum of every position's change in weight between the two month ends, new and sold positions included; price moves alone raise it.
- 6.17%
Changes in Sep 2026
| What changed. New: not held the month before. Added or trimmed: more or fewer units than the month before, or, where no units are stated, a weight that moved by more than a tenth. Sold out: held the month before, gone now. Matured: a bond or deposit whose repayment date fell between the two portfolios, so it was repaid rather than sold (one sold in its last days reads the same). | Change in weight. The holding's weight this month less its weight the month before, in percentage points; a price move alone changes it. | ||||
|---|---|---|---|---|---|
| Alkem Laboratories | New | 2.96% | 0.00% | +2.96 pts | +23,236 |
| Laurus Labs | Added | 3.91% | 2.36% | +1.55 pts | +30,000 |
| Turtlemint Fintech Solutions | Sold out | – | 0.92% | −0.92 pts | −2,59,602 |
| Divi's Laboratories | Trimmed | 9.75% | 10.55% | −0.80 pts | −2,694 |
| Sun Pharmaceutical Industries | Added | 8.96% | 8.21% | +0.75 pts | +32,000 |
| Piramal Pharma | Trimmed | 6.36% | 6.72% | −0.36 pts | −25,000 |
| Mtar Technologies | Sold out | – | 0.26% | −0.26 pts | −1,500 |
Weights are per cent of the fund's net assets; a change in weight is in percentage points.
Holdings month by month
| Holding | Oct 25 | Nov 25 | Dec 25 | Jan 26 | Feb 26 | Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Divi's Laboratories | 8.81% | 8.41% | 8.85%Added | 8.90% | 9.21% | 8.95% | 9.10% | 9.07% | 8.40% | 9.67% | 10.55% | 9.75%Cut |
 Sun Pharmaceutical Industries | 7.66% | 8.24% | 8.01% | 7.90% | 8.40% | 9.41%Added | 9.00% | 6.54%Cut | 6.36% | 8.87%Added | 8.21% | 8.96%Added |
 Piramal Pharma | 3.24% | 4.40%Added | 4.19% | 4.00% | 6.21%Added | 5.69% | 6.27% | 6.51% | 6.04%Added | 6.60% | 6.72% | 6.36%Cut |
 Rubicon Research | 2.35%Bought | 2.47% | 3.11%Added | 3.33% | 3.70% | 3.84% | 4.48% | 4.52% | 6.02%Added | 6.01% | 6.81% | 6.08% |
 Aurobindo Pharma | 3.18% | 5.54%Added | 5.53% | 6.01% | 5.93% | 6.63% | 6.57% | 6.17%Cut | 6.52%Added | 6.13% | 6.18% | 6.03% |
 Apollo Hospitals Enterprise | 6.26% | 5.93% | 5.90% | 6.20% | 6.80% | 6.75% | 6.46% | 6.73% | 6.71% | 6.50% | 6.00% | 5.51% |
 Torrent Pharmaceuticals | 1.09%Cut | 1.13% | 1.22% | 1.33% | 5.46%Added | 5.57% | 5.13% | 5.26% | 5.26%Added | 5.48% | 5.03% | 4.78% |
 Emcure Pharmaceuticals | 3.22% | 3.43% | 3.42% | 3.91% | 3.79% | 4.35% | 4.26% | 4.18% | 4.36%Added | 4.37% | 3.84% | 4.03% |
 Laurus Labs | – | – | – | – | – | 1.65%Bought | 1.70% | 2.05% | 2.14% | 2.41% | 2.36% | 3.91%Added |
 Neuland Laboratories | 4.09% | 4.26% | 3.87% | 3.60% | 3.40% | 3.42%Added | 3.96% | 4.39% | 4.59%Added | 4.42% | 4.11%Cut | 3.82% |
 Max Healthcare Institute | 1.20% | 1.20% | 1.12% | 1.09% | 4.40%Added | 4.06% | 3.90% | 3.68% | 4.16%Added | 3.80% | 3.35% | 2.99% |
 Alkem Laboratories | 1.34%Cut | Sold out | – | – | – | – | – | – | – | – | – | 2.96%Bought again |
 Zydus Lifesciences | – | – | – | – | – | – | – | 1.46%Bought | 1.40%Cut | 1.33% | 2.56%Added | 2.57% |
 IPCA Laboratories | 1.91% | 2.17% | 2.19% | 2.42% | 2.45% | 2.69% | 2.39% | 2.31% | 2.43% | 2.34% | 2.46% | 2.40% |
 Fortis Healthcare | 3.66%Cut | 3.26% | 3.25% | 3.33% | 3.60% | 3.18% | 3.43% | 3.36% | 3.25% | 3.01% | 2.69% | 2.28% |
Per cent of the fund's net assets at each month end, Oct 2025 to Sep 2026. Under it, the change on the fund's previous month. "After a gap" is a holding after a month with no portfolio on record, so when it was bought is not known; "Not filed" is one gone across such a gap.
Portfolio turnover, per cent of assets a year
- TurnoverPortfolio turnover. How much of the portfolio the fund bought or sold over the last year, as a share of its assets, as the fund house states it.
Highest 82.0% in May 2026
Risk ratios
NAV to 23 Oct 2026
Each bar runs from the lowest to the highest figure among the Regular plans of Sectoral / Thematic funds (227 funds) over the same 1 year; the tick is their average and the dot this fund.
How much the NAV moves
Standard deviationStandard deviation. How far the fund's monthly returns spread around their average, stated as a yearly figure: the wider the spread, the more the NAV moves.16.41%
12.43%Lowest20.05%Average46.92%Highest
Downside deviationDownside deviation. Standard deviation counting only the months in which the fund lost money, stated as a yearly figure.9.04%
4.45%Lowest13.49%Average21.72%Highest
Sharpe ratioSharpe ratio. The monthly return above the 91-day Treasury bill yield, divided by its standard deviation and stated for a year: the extra return for each unit of movement in the NAV.0.93
−1.33Lowest0.01Average1.81Highest
Sortino ratioSortino ratio. The monthly return above the 91-day Treasury bill yield, divided by how far it fell below that yield and stated for a year: the extra return for each unit of movement on the way down.1.54
−1.46Lowest0.10Average4.21Highest
Against BSE Healthcare TRI
BetaBeta. How much the fund's monthly return moved for each 1% move in its benchmark: 1 moves with it, below 1 moves less.1.01
0.55Lowest0.97Average of 218 funds1.46Highest
R-squaredR-squared. The share of the fund's monthly movement that its benchmark's movement explains, from 0 to 100.86.4
27.0Lowest89.5Average of 218 funds99.3Highest
CorrelationCorrelation. How closely the fund's monthly returns moved in step with its benchmark's, from minus 1 (always opposite) to 1 (always together).0.93
0.52Lowest0.94Average of 218 funds1.00Highest
Upside captureUpside capture. The fund's return in the months its benchmark rose, as a percentage of the benchmark's return in those months.117.4%
57.0%Lowest104.4%Average of 185 funds178.4%Highest
Downside captureDownside capture. The fund's return in the months its benchmark fell, as a percentage of the benchmark's fall in those months.Needs 6 falling months
Information ratioInformation ratio. The fund's return above its benchmark, divided by how much that difference varied, as stated by the fund house.To 30 Sep 20260.74
Largest falls
| Largest over | FallLargest fall. The biggest drop in NAV from a high to the low that followed, before the NAV went back above that high. | High on | Low on | Back at the highBack at the high. The first day the NAV closed at or above the high it had fallen from. |
|---|---|---|---|---|
| 1 year | −11.14% | 8 Sep 2026 | 23 Oct 2026 | Not yet |
| Since Dec 2024 | −15.91% | 2 Jan 2025 | 28 Feb 2025 | 6 May 2026 |
Risk level by month
| Months | FundRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month. | BenchmarkBenchmark's risk level. The riskometer level of the fund's benchmark index for the same month, on the same six-step scale as the fund's own. |
|---|---|---|
| Feb 2025 to Aug 202619 months | Very High | Very HighBSE Healthcare TRI |
The riskometer at each month end, the fund's and its benchmark's. A month with none on record is left out.
Bajaj Finserv Healthcare Fund managers
Managers now
| Manager | Return in the manager's time. The change in the plan's NAV from the day the manager took the fund over to the latest NAV; past a year, the yearly rate that would compound to the same change. | Benchmark over the same days. The change in the fund's benchmark index over the same days as the manager's return, worked out the same way, with the dividends of the index's companies added back. | Difference from the benchmark. The fund's return in the manager's time less its benchmark's over the same days, in percentage points. | Portfolio changed after the handover. How much of the portfolio was different three months after the manager took over: half the sum of every holding's change in weight, with each side's holdings scaled to add up to 100 so a move into cash does not count. | Portfolio changed before the handover. The same measure over the three months before the manager took over, since portfolios change anyway. | Assets the manager runs. The latest monthly size of every fund the manager runs now, added up; a fund run with others counts in full for each of its managers, and the line under it counts only the funds they run alone. | ||
|---|---|---|---|---|---|---|---|---|
| Bharat HegdeEquity Portion | May 2026 | +5.80%over 150 days | – | – | 15.4% | 18.8% | 1 | ₹405 Cr |
| Sorbh Gupta(Equity Portion) (Primary); Equity Portion | Sep 2026 | – | – | – | – | – | 9 | ₹18,555 Cr |
| Siddharth Chaudhary(Debt Portion) (Primary); Debt Portion | Dec 2024 | +5.25%a year | – | – | 26.5% | – | 20 | ₹36,004 Cr₹577 Cr alone |
Returns are the regular plan's growth NAV, from the day each took over to the latest NAV, beside the benchmark over the same days.
Managers before
| Manager | Return in the manager's time. The change in the plan's NAV from the day the manager took the fund over to the latest NAV; past a year, the yearly rate that would compound to the same change. | Benchmark over the same days. The change in the fund's benchmark index over the same days as the manager's return, worked out the same way, with the dividends of the index's companies added back. | Difference from the benchmark. The fund's return in the manager's time less its benchmark's over the same days, in percentage points. | ||
|---|---|---|---|---|---|
| Vinay Bafna | May 2026 | Sep 2026 | +11.65%over 132 days | – | – |
Other funds they run
| Fund | Return in the manager's time. The change in the plan's NAV from the day the manager took the fund over to the latest NAV; past a year, the yearly rate that would compound to the same change. | Benchmark over the same days. The change in the fund's benchmark index over the same days as the manager's return, worked out the same way, with the dividends of the index's companies added back. | Difference from the benchmark. The fund's return in the manager's time less its benchmark's over the same days, in percentage points. | ||
|---|---|---|---|---|---|
| Bajaj Finserv Flexi Cap FundSorbh Gupta | – | – | – | ₹8,527 Cr | |
| Bajaj Finserv Small Cap FundSorbh Gupta | – | – | – | ₹2,762 Cr | |
| Bajaj Finserv Large & Mid Cap FundSorbh Gupta | – | – | – | ₹2,324 Cr | |
| Bajaj Finserv Multi Cap FundSorbh Gupta | – | – | – | ₹1,641 Cr | |
| Bajaj Finserv Large Cap FundSorbh Gupta | – | – | – | ₹1,560 Cr | |
| Bajaj Finserv Balanced Advantage FundSorbh Gupta | – | – | – | ₹1,207 Cr | |
| Bajaj Finserv ELSS - Tax Saver FundSorbh Gupta | – | – | – | ₹88 Cr | |
| Bajaj Finserv Equity Savings FundSorbh Gupta | – | – | – | ₹40 Cr | |
| Bajaj Finserv Flexi Cap FundSiddharth Chaudhary | – | – | – | ₹8,527 Cr | |
| Bajaj Finserv Liquid FundSiddharth Chaudhary | Jul 2023 | +6.74%a year | – | – | ₹6,863 Cr |
Up to ten funds a manager, largest first. Returns are the regular plan's.
Portfolio overlap
Funds holding the most of the same securities, by weight.
Closest funds in the category
| Portfolio overlap. The share of the two funds' portfolios that is the same: for every holding they share, the smaller of its two weights, added up. | Shared holdings. The number of securities both funds hold, cash and futures left out. | |
|---|---|---|
| ITI Pharma and Healthcare FundITI Mutual Fund | 58.68% | 19 |
| Mirae Asset Healthcare FundMirae Asset Mutual Fund | 55.73% | 18 |
| LIC Mf Healthcare FundLIC Mutual Fund | 53.39% | 15 |
| WhiteOak Capital Pharma and Healthcare FundWhiteOak Capital Mutual Fund | 52.20% | 21 |
| HDFC Pharma and Healthcare FundHDFC Mutual Fund | 50.10% | 17 |
| Baroda BNP Paribas Health and Wellness FundBaroda BNP Paribas Mutual Fund | 49.14% | 15 |
| Aditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Mutual Fund | 46.62% | 20 |
| Kotak Healthcare FundKotak Mahindra Mutual Fund | 44.79% | 15 |
| Nippon India Pharma FundNippon India Mutual Fund | 44.40% | 17 |
| SBI Healthcare Opportunities FundSBI Mutual Fund | 43.26% | 12 |
Portfolios for Sep 2026. Overlap is per cent of the portfolio the two funds hold in common.
Overlap with the fund house's other funds
| Portfolio overlap. The share of the two funds' portfolios that is the same: for every holding they share, the smaller of its two weights, added up. | |
|---|---|
| Bajaj Finserv Large & Mid Cap FundBajaj Finserv Mutual Fund | 13.09% |
| Bajaj Finserv Flexi Cap FundBajaj Finserv Mutual Fund | 13.05% |
| Bajaj Finserv Small Cap FundBajaj Finserv Mutual Fund | 11.74% |
| Bajaj Finserv Large Cap FundBajaj Finserv Mutual Fund | 9.51% |
| Bajaj Finserv ELSS - Tax Saver FundBajaj Finserv Mutual Fund | 9.40% |
| Bajaj Finserv Multi Cap FundBajaj Finserv Mutual Fund | 7.98% |
| Bajaj Finserv Consumption FundBajaj Finserv Mutual Fund | 7.36% |
| Bajaj Finserv Banking and Financial Services FundBajaj Finserv Mutual Fund | 1.67% |
As the fund house states it, for Sep 2026.
Changes to the fund
Newest first.
2026
- 1 AprExpenseExpense ratio stated under the new rules: a base ratio, with brokerage, levies and GST on top
Fund details
Objective
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.
Asset allocation
- Equity and Equity Related Securities of pharma, healthcare and allied companies - 80% - 100%, Equities and Equity related securities of other than pharma, healthcare and allied companies - 0% - 20%
- Money market instruments*, other liquid instruments, Units of InvITs, Units of Gold ETFs and Silver ETFs and units of Liquid, Overnight and Money Market Mutual Fund - 0% - 20%
*Money market instruments will include commercial papers,commercial bills, Triparty REPO, Reverse Repo and equivalent and any other like instruments as specified by SEBI and Reserve Bank of India from time to time.
Type of scheme
An open ended equity scheme investing in pharma, healthcare and allied theme
- Stated category
- Thematic Fund
- BenchmarkBenchmark. The index the fund house chose to measure the fund against, in its total return form, with dividends added back.
- BSE Healthcare Total Return Index (TRI)
- Risk level at launchRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month.
- Very High
- New fund offer
- 6 Dec 2024 to 20 Dec 2024
- Units first allotted
- 27 Dec 2024
- Price at the offer
- ₹10 a unit
- Minimum at the offer
- ₹500
Plans and codes
| Plan | AMFI code | ISIN | ISIN, reinvestment | MUTF_IN | First NAV |
|---|---|---|---|---|---|
| Direct Growth | 153157 | INF0QA701AB9 | BAJA_HEAL_DIR_M02BU0 | 30 Dec 2024 | |
| Regular Growth | 153155 | INF0QA701987 | BAJA_HEAL_REG_MHZJ31 | 30 Dec 2024 | |
| Direct IDCW | 153156 | INF0QA701AC7 | INF0QA701AD5 | BAJA_HEAL_DIR_E7RIRG | 30 Dec 2024 |
| Regular IDCW | 153158 | INF0QA701995 | INF0QA701AA1 | BAJA_HEAL_REG_18FSFI8 | 30 Dec 2024 |
This fund
- Scheme information document (opens in a new tab)The fund's objective, terms, costs and risks in full
Factsheet
- Bajaj AMC Factsheet October 2026 (opens in a new tab)Bajaj Finserv Mutual Fund, Oct 2026
Statement of additional information
- SAI Bajaj Finserv Mutual Fund (opens in a new tab)Bajaj Finserv Mutual Fund, Oct 2026
Annual report
- Bajaj Finserv Mutual Fund Annual Financials March 2026 (opens in a new tab)Bajaj Finserv Mutual Fund, Mar 2026
- Bajaj Finserv Mutual Fund – Abridged financial 2025-26 (opens in a new tab)Bajaj Finserv Mutual Fund, Mar 2026
Riskometer disclosure
- Details of Risk-o-meter of schemes of Bajaj Finserv Mutual Fund (opens in a new tab)Bajaj Finserv Mutual Fund, Mar 2026
Portfolio overlap disclosure
- Bajaj AMC Portfolio Overlap September 2026 Download (opens in a new tab)Bajaj Finserv Mutual Fund, Sep 2026